Business & Industry
Novartis and BoomRay Enter Global License Agreement for Preclinical Radioligand Therapy Asset
Novartis has entered into an exclusive global license agreement with BoomRay Pharmaceuticals for an undisclosed preclinical radioligand therapy asset, with total potential payments to BoomRay reaching up to $900 million.
Announced on September 22, 2026, this radioligand license deal brings...
Clinical Trials
Roche Obesity Drug Enicepatide Delivers 15.5% Weight Loss and Blood Sugar Reduction in Mid-Stage Trial
Swiss pharmaceutical company Roche has announced that its experimental dual-acting obesity drug, enicepatide, helped overweight or obese patients living with type 2 diabetes achieve an average body weight reduction of 15.5% while also significantly lowering blood sugar levels in...
Business & Industry
UK Launches £45M Research Partnership Funding and Unveils First Workplace Health System Plan
The UK's National Institute for Health and Care Research (NIHR) has opened the first funding round for its Strategic Infrastructure Partnerships programme, inviting applications for a share of £45 million aimed at accelerating the translation of early-stage medical discoveries...
News
Temperature Mapping for GMP Warehouses: What Auditors Expect to See
Temperature mapping is one of the most frequently inspected elements of GMP warehouse qualification, and the gap between documentation that satisfies an auditor and documentation that raises questions is often a matter of how well the mapping study was...
Business & Industry
ACHEMA 2027 Strengthens India Process Industry Collaboration
DECHEMA, EEPC INDIA and Messe Frankfurt India brought together more than 200 industry leaders, business stakeholders and professionals from India’s process, chemical, pharmaceutical and engineering sectors at a Networking Evening in New Delhi on 8 September 2026. Held at...
News
Onyx Scientific Boosts API Manufacturing Capacity in UK
Onyx Scientific, a global small molecule CDMO, is investing more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities and increase commercial active pharmaceutical ingredient (API) production at its Sunderland UK facility. The expansion will add four GMP...
Business & Industry
Strengthening Supply Chain Visibility for Safe Medicines
A comprehensive survey of 5,000 patients across the United States, the United Kingdom, France, and Germany indicates that pharmaceutical manufacturers have a timely opportunity to build consumer trust through enhanced traceability. With six in 10 respondents voicing concern that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read